She is status post 1 full cycle of carboplatin 5 AUC D1 and gemcitabine D1, D8, last dose [**2113-2-2**].
On arrival to the ED, initial vs were: HR 140 BP 152/76 RR 18 POx 94 O2 sat.
Initial labs confirmed pancytopenia.
A CT ab/pelvis was performed concerning for possible SBO and ischemia and surgery was consulted who feel patient is not a surgical candidate.
VS prior to transfer T 98.2 HR 104 BP 132/64 RR 18 100% on FIO2, on trache AC.
Family History: NC, no known lung cancer  Physical Exam: General: intubated and sedated HEENT: pupils pinpoint and minimally reactive, Sclera anicteric but edematous, MMD, oropharynx clear Neck: supple, JVP unable to assess [**1-10**] body habitus, no LAD Lungs: Coarse throughout, rhonorus at right base, no wheezes, right pleurex catheter w/out drainage CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Abdomen: distended, tympanitic, not tense,no bowel sounds present, unable to assess for tenderness [**1-10**] sedation G-tube to suction GU: foley - 170 cc urine made in ED, yellow Ext: warm, well perfused, 1+ pulses, anasarcic, no mottling   Pertinent Results: [**2-6**] CXR: IMPRESSION: Interval increase in large bilateral pleural effusions with overlying atelectasis.
[**2-7**] CT abd/pelvis: IMPRESSION: 1.
[**2113-2-6**] 09:30PM BLOOD WBC-0.1*# RBC-2.56* Hgb-7.1* Hct-21.8* MCV-85 MCH-27.8 MCHC-32.7 RDW-13.6 Plt Ct-15*# [**2113-2-7**] 01:00AM BLOOD WBC-0.1* RBC-2.01* Hgb-5.8* Hct-17.2* MCV-86 MCH-28.8 MCHC-33.7 RDW-13.9 Plt Ct-11* [**2113-2-7**] 12:47PM BLOOD WBC-0.1* RBC-3.13* Hgb-9.0* Hct-26.2* MCV-84 MCH-28.9 MCHC-34.5 RDW-14.0 Plt Ct-60* [**2113-2-8**] 03:10AM BLOOD WBC-0.1* RBC-3.01* Hgb-8.8* Hct-25.0* MCV-83 MCH-29.2 MCHC-35.2* RDW-14.6 Plt Ct-16*# [**2113-2-6**] 09:30PM BLOOD Neuts-34* Bands-0 Lymphs-64* Monos-0 Eos-2 Baso-0 Atyps-0 Metas-0 Myelos-0 [**2113-2-6**] 09:30PM BLOOD Plt Smr-RARE Plt Ct-15*# [**2113-2-7**] 10:32AM BLOOD Plt Ct-63*# [**2113-2-8**] 03:10AM BLOOD Plt Smr-RARE Plt Ct-16*# [**2113-2-6**] 09:30PM BLOOD Glucose-164* UreaN-18 Creat-0.4 Na-138 K-3.0* Cl-101 HCO3-31 AnGap-9 [**2113-2-8**] 03:10AM BLOOD Glucose-162* UreaN-21* Creat-0.4 Na-140 K-2.8* Cl-109* HCO3-26 AnGap-8 [**2113-2-6**] 09:30PM BLOOD ALT-398* AST-151* LD(LDH)-172 CK(CPK)-41 AlkPhos-246* TotBili-0.8 [**2113-2-8**] 03:10AM BLOOD ALT-297* AST-75* LD(LDH)-168 AlkPhos-146* TotBili-0.8 [**2113-2-6**] 09:30PM BLOOD cTropnT-<0.01 [**2113-2-6**] 09:30PM BLOOD Calcium-6.9* Phos-4.0 Mg-1.1* [**2113-2-8**] 03:10AM BLOOD Calcium-7.8* Phos-3.4 Mg-2.2 [**2113-2-7**] 05:02AM BLOOD Type-ART Temp-36.6 pO2-158* pCO2-35 pH-7.49* calTCO2-27 Base XS-4 [**2113-2-8**] 06:26AM BLOOD Type-ART Temp-36.1 pO2-78* pCO2-57* pH-7.32* calTCO2-31* Base XS-0 [**2113-2-6**] 10:05PM BLOOD Lactate-0.8 [**2113-2-7**] 05:02AM BLOOD freeCa-1.00* [**2113-2-8**] 06:26AM BLOOD freeCa-1.27  Brief Hospital Course: 56 yo F with stage IV NSCLC, on palliative chemotherapy s/p [**Doctor Last Name **]/gemcitabine last dose 2/25 presents from NH with nausea/vomiting/diarrhea and febrile neutropenia admitted to [**Hospital Unit Name 153**] with septic shock.
Unable to trend SvO2 or CVP 2/2 SVC syndrome and inability to place upper extremity central line.
Blood cultures and urine cultures showed no growth, so her antibiotics were streamlined to cefepime/cipro/flagyl.
Stool was negative for cdiff.
She was started on GCSF per oncology recommendations and her CBC was monitored daily with transfusion goals of HCT>21, plts >10.
As mentioned above, the patient was covered broadly with antibiotics; blood, stool, urine, and sputum cultures were all unrevealing.
Her WBC blood count remained at 0.1 until [**2-12**] and on [**2-13**] her WBC count improved to 8.8.
Her WBC was elevated at 41.8 on [**2113-2-16**], and this was felt to be secondary to GCSF treatment, last given on [**2-13**].
SBO vs. ileus - thought to to be infection associated ileus, as pt was putting out stool, had bowel sounds, and admission CT abdomen not convincing of SBO.
She was monitored with serial abdominal exams and her tube feeds were initially held then restarted at a low rate on [**2113-2-8**].
Cultures of pleural fluid were negative.
She required numerous transfusions of platelets and pRBC's during her hospital stay to maintain a hematocrit above 21 and platelets above 10K.
Docusate Sodium 50 mg/5 mL Liquid [**Hospital1 **]: Two (2)  PO BID (2 times a day) as needed for constipation.
Polyethylene Glycol 3350 17 gram/dose Powder [**Month/Day (2) **]: One (1) PO DAILY (Daily) as needed for constipation.
Methylprednisolone Sodium Succ 40 mg/mL Recon Soln [**Month/Day (2) **]: Twenty Five (25) mg Injection Q24H (every 24 hours).
[**Initials (NamePattern4) **] [**Last Name (NamePattern4) **] [**Name8 (MD) **] MD [**MD Number(1) 292**]  Completed by:[**2113-2-17**
